Johnson & Johnson JNJ reported second-quarter earnings of $2.58 per share, which beat the analyst consensus estimate of $2.43. This is a 22.86% increase over earnings of $2.1 per share from the same period last year.
The company reported quarterly sales of $20.56 billion, which beat the analyst consensus estimate of $20.29 billion. This is a 1.30% decrease over sales of $20.83 billion the same period last year.
Johnson & Johnson reaffirms 2019 adjusted EPS guidance of $8.53-$8.63 versus $8.60 estimates.
Johnson & Johnson's stock traded higher by 0.9% at $135.95 in Tuesday's pre-market session. The stock has a 52-week high of $148.99 and a 52-week low of $121
Related Links:
Johnson & Johnson Falls On Report Of Justice Department Probe
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
